Can Ozempic Cause Diarrhea: Exploring Side Effects & Management
Learn whether Ozempic can cause diarrhea. Understand how to manage stomach discomfort and ensure comfort while on the medication.
- Does Ozempic Lead to Diarrhea?
- Understanding the Causes of Diarrhea with Ozempic
- How to Manage Diarrhea When Taking Ozempic
- Comparing Diarrhea in Ozempic with Other Medications for Weight Loss
- Get Tailored Support Managing Your Ozempic Treatment
Ozempic, made with the active ingredient semaglutide, has become increasingly popular for its efficacy in treating type 2 diabetes and obesity (1). However, like all medications, it may present side effects, among which gastrointestinal disturbances are common (1). Diarrhea has been reported by many Ozempic users and researched in clinical studies, which found that up to 31.5% of its participants on Semaglutide experience diarrhea (1). Understanding this side effect can help users and healthcare providers mitigate its impact and make informed decisions about its use.
Does Ozempic Lead to Diarrhea?
Clinical trials and user testimonials indicate that using Ozempic can lead to diarrhea in some individuals. While not everyone taking Ozempic will experience diarrhea, it's recognized as a common side effect (1). It's essential to differentiate between occasional, mild diarrhea and more severe, persistent diarrhea that could be due to an intolerable medication dose or underlying infection or condition. Severe, persistent diarrhea necessitates medical attention.
Understanding the Causes of Diarrhea with Ozempic
Ozempic works by mimicking a hormone that targets areas of the brain involved in appetite regulation, leading to reduced hunger and calorie intake (2). Additionally, it slows gastric emptying, which helps control blood sugar levels (3,4).
The mechanism by which Ozempic can cause diarrhea is not fully understood. Nonetheless, GLP-1 medications are known to disrupt normal digestive processes and change the intestinal environment in a variety of ways, which may contribute to diarrhea:
- Changes in gut motility (5)
- Changes in the gut microbiota cause altered fluid absorption in the intestines (6)
- A direct effect on the gastrointestinal lining (7)
How to Manage Diarrhea When Taking Ozempic
Dealing with diarrhea while on Ozempic involves a combination of tactics focused on diet, hydration, and, sometimes, medication adjustments. Here are some strategies:
- Stay Hydrated: The most critical therapy is rehydration! Diarrhea increases the risk of dehydration as you’re losing lots of watery stool. Drinking electrolyte-rich fluids rich in salt and sugar can help maintain hydration. Examples of rehydrating fluids include diluted fruit juice, soda, or bone broths with saltine crackers (8)
- Adjust Your Diet: The benefits of specific dietary recommendations other than rehydrating have not been established. However, ensuring sufficient nutrition is crucial for replenishing electrolytes (9). Opt for bland, easy-to-digest foods such as potatoes, noodles, rice, crackers, bananas, soup, and boiled vegetables (10).
- Consult Your Healthcare Provider: Seek medical advice for severe or persistent diarrhea. Adjusting the Ozempic dosage or switching medications may be necessary. Furthermore, they may suggest an antidiarrheal agent to help ease symptoms.
- Probiotics: There is no proven benefit of taking probiotics to help restore healthy gut flora balance.
Comparing Diarrhea in Ozempic with Other Medications for Weight Loss
Understanding the side effect profile is crucial when choosing the right medication for diabetes management or weight loss. Ozempic is not the only medication taken for weight loss that causes diarrhea.
Gastrointestinal disturbances, including diarrhea, are a well-known and common side effect of all GLP-1 medications approved for diabetes and weight loss (11). However, the benefits of glycemic control and weight reduction must be weighed against the risk of side effects. Each medication in this class has a unique profile, and responses can vary greatly among individuals. Explore other medications here: https://joinmochi.com/medications
In conclusion, diarrhea is a common side effect of Ozempic and represents a potential barrier to its use, especially at higher doses. However, there are strategies to manage diarrhea, and your healthcare provider can work with you to optimize your medication regimen. As always, it's best to discuss your concerns with a healthcare provider to ensure the benefits of using Ozempic outweigh any side effects.
Get Tailored Support Managing Your Ozempic Treatment
If you're considering Ozempic for weight management, it's essential to have a knowledgeable and trustworthy care team by your side. Joining Mochi Health's weight care program can provide invaluable resources and personalized strategies to maximize results and mitigate side effects while on Ozempic. Our healthcare providers are well-versed in managing side effects, including diarrhea, and can work with you to tailor your treatment plan based on your individual needs. Through thorough communication and ongoing support, we aim to ensure that you not only navigate the challenges of weight loss but also achieve lasting success. Embrace a healthier lifestyle today—take the first step and find out if you’re eligible for our program today.
Sources:
- Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989–1002. https://www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
- Gabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rønne J, Alanentalo T, Baquero AF, et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight. 2020 Mar 26;5(6). https://insight.jci.org/articles/view/133429
- Weber MM. Trust the Gold Standard: All Glucagon-like Peptide-1 Receptor Agonists Can Delay Gastric Emptying. Anesthesiology. 2024 Jan 1;140(1):178–80. https://pubs.asahq.org/anesthesiology/article-abstract/140/1/178/139381/Trust-the-Gold-Standard-All-Glucagon-like-Peptide?redirectedFrom=fulltext
- Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emptying in diabetes: an overview. Diabet Med. 1996 Sep;13(9 Suppl 5):S16-22. https://pubmed.ncbi.nlm.nih.gov/8894465/
- Banks KP, Syed K, Parekh M, et al. Gastric Emptying Scan. [Updated 2023 Sep 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK531503/
- Kato, S., Sato, T., Fujita, H. et al. Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms. Sci Rep 11, 9167 (2021). https://www.nature.com/articles/s41598-021-88612-x
- Fass, R., McCallum, R. W., & Parkman, H. P. (2009). Treatment Challenges in the Management of Gastroparesis-Related GERD. Gastroenterology & hepatology, 5(10 Suppl 18), 4–16. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886367/
- Avery, M. E., & Snyder, J. D. (1990). Oral therapy for acute diarrhea. The underused simple solution. The New England journal of medicine, 323(13), 891–894. https://www.nejm.org/doi/10.1056/NEJM199009273231307?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
- Duggan, C., Santosham, M., & Glass, R. I. (1992). The management of acute diarrhea in children: oral rehydration, maintenance, and nutritional therapy. Centers for Disease Control and Prevention. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 41(RR-16), 1–20. https://www.cdc.gov/mmwr/preview/mmwrhtml/00018677.htm
- Riddle, M. S., DuPont, H. L., & Connor, B. A. (2016). ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. The American journal of gastroenterology, 111(5), 602–622. https://journals.lww.com/ajg/fulltext/2016/05000/acg_clinical_guideline__diagnosis,_treatment,_and.14.aspx
- Wharton, S., Davies, M., Dicker, D., Lingvay, I., Mosenzon, O., Rubino, D. M., & Pedersen, S. D. (2022). Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgraduate Medicine, 134(1), 14–19. https://www.tandfonline.com/doi/full/10.1080/00325481.2021.2002616